1′-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway.

MLA

Pang, Xiufeng, et al. “1′-Acetoxychavicol Acetate Suppresses Angiogenesis-Mediated Human Prostate Tumor Growth by Targeting VEGF-Mediated Src-FAK-Rho GTPase-Signaling Pathway.” Carcinogenesis, vol. 32, no. 6, June 2011, pp. 904–12. EBSCOhost, https://doi.org/10.1093/carcin/bgr052.

APA

Pang, X., Zhang, L., Lai, L., Chen, J., Wu, Y., Yi, Z., Zhang, J., Qu, W., Aggarwal, B. B., & Liu, M. (2011). 1′-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway. Carcinogenesis, 32(6), 904–912. https://doi.org/10.1093/carcin/bgr052

Chicago

Pang, Xiufeng, Li Zhang, Li Lai, Jing Chen, Yuanyuan Wu, Zhengfang Yi, Jian Zhang, Weijing Qu, Bharat B. Aggarwal, and Mingyao Liu. 2011. “1′-Acetoxychavicol Acetate Suppresses Angiogenesis-Mediated Human Prostate Tumor Growth by Targeting VEGF-Mediated Src-FAK-Rho GTPase-Signaling Pathway.” Carcinogenesis 32 (6): 904–12. doi:10.1093/carcin/bgr052.